F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices

The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.

Stay up to date
Register now to get updates on promotions and coupons
HTML Snippets Powered By : XYZScripts.com

Shopping cart

×